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Arabidopsis mutants produced by constitutive overexpression of the CRISPR/Cas9 genome editing system are
usually mosaics in the T1 generation. In this study, we used egg cell-specific promoters to drive the expression of
Cas9 and obtained non-mosaic T1 mutants for multiple target genes with high efficiency. Comparisons of 12
combinations of eight promoters and two terminators found that the efficiency of the egg cell-specific promoter-
controlled CRISPR/Cas9 system depended on the presence of a suitable terminator, and the composite promoter
generated by fusing two egg cell-specific promoters resulted in much higher efficiency of mutation in the T1
generation compared with the single promoters.Background
The large collections of Arabidopsis sequence-indexed T-
DNA insertion mutants (over 325,000 lines) have played a
critical role in direct investigations of gene function [1].
However, two major obstacles limit the application of
these collections for genome-wide phenomic screening.
First, most lines are hemizygous for the insertion, and thus
have required an extra genotyping step to identify homo-
zygous plants for phenotyping. Second, no T-DNA inser-
tion mutants are available for 12 % of genes, and 8 % of
genes are only represented by a single allele [2]. Addition-
ally, dissecting the roles of gene family members with re-
dundant functions and analyzing epistatic relationships in
genetic pathways frequently require plants bearing muta-
tions in multiple genes. One hindrance to producing
multi-gene mutants using T-DNA insertion mutagenesis
is that this method requires time-consuming and labor-
intensive genetic crossing of single-mutant plants. Ad-
vances in the use of sequence-specific nucleases, including
homing meganucleases, zinc finger nucleases (ZFNs),
transcription activator–like effector nucleases (TALENs),* Correspondence: qjchen@cau.edu.cn
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Cas9 from the bacterial adaptive immune system CRISPR
(clustered regularly interspaced short palindromic repeats)
have paved the way for the development of rapid, cost-
effective ways to create new mutant populations and
multi-gene mutants in plants [3–7].
The CRISPR/Cas9 system uses an engineered single
guide RNA (sgRNA) to provide sequence specificity, and
depends on the endonuclease activity of the sgRNA/Cas9
complex to produce double-strand breaks at genomic sites
specified by sgRNAs [7–10]; these double-strand breaks
cause the activation of the DNA repair system in host
cells, usually via the non-homologous end-joining path-
way [5]. Since the repair pathway is error-prone, small de-
letions or insertions will be introduced during the repair
process, thus producing mutations [5]. This highly effi-
cient, easy-to-use system can potentially be used to make
highly multiplexed genome modifications, and is supplant-
ing the use of ZFNs and TALENs to become the standard
genome-editing technology [3, 4, 6, 7]. In vertebrates,
coinjection of in vitro transcribed Cas9 mRNA and
sgRNA into single-cell embryos can produce multi-gene,
biallelic mutant animals with high efficiency; the multiple
mutations can also be efficiently transmitted to the next
generation [11–16]. In plants, however, the presence oficle distributed under the terms of the Creative Commons Attribution License
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tical. Creating transgenic lines expressing the CRISPR/Cas9
system provides an alternative method [17–44].
Agrobacterium-mediated techniques used to create trans-
genic plant lines include in planta transformation and em-
bryogenic callus-based transformation. The most typical
example of in planta transformation is Agrobacterium-me-
diated transformation of Arabidopsis, whose egg cell is the
target of the T-DNA [45–48]. Embryogenic cell-derived
transgenic lines expressing the CRISPR/Cas9 system can
be homozygous for edited target genes in the first gener-
ation, indicating that the target genes were edited in the
transformed embryogenic cells before the first cell division
[28]. Similar results were reported in tomato [33] and
maize [26]. These results are encouraging for the develop-
ment of crop genome editing, since crop transformation
usually uses embryogenic callus cells, which can be con-
sidered to be analogous to animal embryos at the one-cell
stage. In Arabidopsis, which is highly amenable to in
planta transformation, the CRISPR/Cas9 system should
theoretically be able to function in one-cell stage embryos.
However, transgenic lines expressing CRISPR/Cas9 have
mainly been mosaic in the first generation (T1), indicating
that CRISPR/Cas9-induced mutations in Arabidopsis oc-
curred after the first embryonic cell division [20, 22, 25,
26, 29, 35]. Perhaps the failure of CRISPR/Cas9 to func-
tion in one-cell stage embryos was due to the weak activity
of the constitutive Cauliflower Mosaic Virus 35S promoter
(CaMV 35S) in egg cells and one-cell stage embryos.
In this study, we used the promoter of the egg cell-
specific EC1.2 gene [49, 50] to drive the expression of
Cas9 in Arabidopsis, demonstrating that the specific ex-
pression of CRISPR/Cas9 in egg cells and one-cell stage
embryos could efficiently lead to the creation of homozy-
gous or biallelic mutants for multiple target genes in Ara-
bidopsis in the T1 generation. Identification of completely
mutated, non-mosaic lines will usually require medium-
depth sequencing of target loci in a few candidate lines
screened from 25–50 T1 transgenic plants via restriction
enzyme digestion analysis, T7E1 assay, or Surveyor assay.
However, the present strategy could shorten the time re-
quired to produce such mutants to a single generation,
thus providing a quicker, more cost-effective means of cre-
ating new mutant populations and multi-gene mutants in
Arabidopsis. Based on comparisons of different combina-
tions of promoters and terminators, we also present a
route to optimize the egg cell-specific promoter-
controlled (EPC) CRISPR/Cas9 system.
Results
Targeted mutations of multiple Arabidopsis genes in the
T1 generation
Two reports have demonstrated that DD45/EC1.2
(At2g21740) is an egg cell-specific gene [49, 50]. In situhybridization of tissue sections revealed that EC1.2 tran-
scripts are specifically present in the egg cell, whereas
GUS activity and GFP signals were observed in EC1.2p:-
GUS and EC1.2p:GFP transgenic zygotes and early em-
bryos; the carryover of the signal into later stages of
embryogenesis likely resulted from higher stability of the
reporter mRNA and/or protein [49, 50]. We reasoned
that Cas9 driven by the EC1.2 promoter would be spe-
cifically transcribed in the egg cell; Cas9 mRNA would
reside in one-cell stage embryos due to mRNA stability
and continue to translate Cas9 protein. Also, newly
translated Cas9, together with residual Cas9 that
remained due to Cas9 protein stability, would function
in one-cell stage embryos, thus allowing creation of Ara-
bidopsis T1 homozygous or biallelic mutants, rather than
mosaic plants.
Since combinations of the same promoter with different
terminators might result in significantly different amounts
of protein [51], we made the two constructs to examine
the effects of two terminators, the Pisum sativum rbcS E9
terminator, in the pHEE2A-TRI construct, and the Agro-
bacterium nos gene terminator, in the pHEN2A-TRI con-
struct, on the expression of Cas9 driven by the EC1.2
promoter (Fig. 1). We used two single guide RNAs
(sgRNAs) to target three genes, ETC2, TRY, and CPC
(Fig. 1a, b), since the try cpc double and etc2 try cpc triple
mutants have easily observed phenotypes (clustered leaf
trichomes) and the triple mutant has a different pheno-
type from the double mutant [26].
In our first attempt, we obtained 24 T1 EC1.2p:zCas9-
rbcS_E9t lines using pHEE2A-TRI (Fig. 1a) and 54 T1
EC1.2p:zCas9-Nost lines using pHEN2A-TRI (Fig. 1a).
Among the 24 T1 EC1.2p:zCas9-rbcS_E9t lines, two lines
(#1 and #3) were likely triple mutants (Fig. 1c), and one line
(#21) was a mosaic with two branches that displayed the
double-mutant and wild-type phenotypes, respectively. We
sequenced the regions surrounding the target sites of the
three genes from the two putative triple mutant lines, and
confirmed that they were indeed triple mutants (Table 1).
In this instance, all observed mutations were single base
pair insertions or deletions. Sequencing analysis and exam-
ination of the phenotypes of T2 plants derived from these
two T1 lines further confirmed the identity of the two mu-
tant lines (Tables 1 and 2). Unexpectedly, we failed to iden-
tify a likely triple mutant, double mutant, or mosaic among
54 T1 EC1.2p:zCas9-Nost lines, suggesting that the com-
bination of the EC1.2 promoter and rbcS E9 terminator
performed much better than the combination of the EC1.2
promoter and nos terminator.
To examine the specificity of the mutagenesis, we
searched the Arabidopsis genome for potential off-
targets with fewer than four mismatches with the targets
of the sgRNAs. This identified three potential off-targets
of the sgRNA targeting ETC2 [52]. We sequenced these
Fig. 1 Arabidopsis T1 homozygous triple mutants obtained via EPC CRISPR/Cas9. a Physical maps of the T-DNAs of two CRISPR/Cas9 binary vec-
tors, each harboring Cas9 driven by the egg-cell specific promoter EC1.2p and two sgRNA genes driven by Pol-III promoters U6-26p and U6-29p,
respectively. RB/LB, T-DNA right/left border; EC1.2p, EC1.2 promoter; rbcS-E9t, rbcS E9 terminator; Nost, nos gene terminator; sgR, sgRNA; 2-sgRs,
two sgRNA expression cassettes; zCas9, Zea mays codon-optimized Cas9; U6-26p and U6-29p, two Arabidopsis U6 gene promoter; U6-26t, U6-26
terminator with downstream sequence; Hyg, hygromycin-resistance gene. For the sgRNAs, the yellow part represents 20-bp target and the green
part represents 76-bp sgRNA scaffold. b The alignment of the sgRNA with its target genes and potential off-targets. Only aligned regions of inter-
est are displayed. rc, reverse complement. c Phenotypes of two triple mutants segregated from T1 transgenic lines. The other plants in the same
pot are from the same batch of T1 transgenic lines with normal phenotypes. Seeds from the T0 plants were sown on MS medium containing
25 mg/L hygromycin, vernalized at 4 °C for 3 days, and grown under long-day conditions (16 h light/8 h dark) at 22 °C for 9 days. Hygromycin-
resistant seedlings (T1) were transplanted to soil and allowed to grow for 33 days before photographing
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tions, demonstrating the high specificity of the EPC
CRISPR/Cas9 system.
To confirm the repeatability of the results from
EC1.2p:zCas9-rbcS_E9t transgenic lines, we performed
two additional, independent Arabidopsis transformation
experiments with the construct pHEE2A-TRI. In the
second transformation, we obtained 41 T1 lines, among
which three were likely triple mutants (Additional file 1:
Figure S1). In the third transformation, we obtained
43 T1 lines, including four that were likely triple mu-
tants (Additional file 1: Figure S2). Therefore, approxi-
mately 8.3 % (9/108) of the T1 plants were likely
homozygous triple mutants.
We also demonstrated the usefulness of the EPC
CRISPR/Cas9 system by performing targeted mutation of
two Arabidopsis genes, CHLI1 and CHLI2, in T1 plants.
Simultaneous disruption of CHLI1 and CHLI2 leads to an
albino phenotype. We obtained 99 T1 lines, including 18
putative chli1 chli2 double mutants (albino plants, seeAdditional file 1: Figure S3). We sequenced the regions sur-
rounding the target sites, and found that 10 lines were
double mutants and five were mosaic plants (Additional file
2: Table S1). These results indicate that the EPC CRISPR/
Cas9 was functional, not only in one-cell stage embryos,
but also in some early embryos, likely due to Cas9 mRNA
and/or protein stability, and/or reduced egg cell-specificity.
Among the 18 albino lines, three grew poorly, and we were
unable to obtain sequence data from these lines (Additional
file 1: Figure S3, Additional file 2: Table S1). These three al-
binos were most likely double mutants rather than mosaics,
based on their poor growth. Thus, the ratio of homozygous
T1 double mutants to T1 plants was approximately 13 %
(13/99). Together, these results demonstrate that our EPC
CRISPR/Cas9 system could be used to efficiently produce
confirmed T1 homozygous or biallelic mutants in less than
3 months (Additional file 3: Figure S4). In practical applica-
tions, users might have no visible phenotypes that they
could use to screen for T1 homozygous mutants. However,
this obstacle can be easily overcome by screening 25–50 T1
Table 1 Mutation analysis of three T1 likely triple mutants and
their T2 progeny
Line ETC2 TRY CPC Genotype
T1 #1 +A/+C −C/−C +A/+T eettcc
T2 1-1 +A/+C −C/−C +A/+T eettcc
1-2 +A/+A −C/−C +A/+A eettcc
1-3 +A/+C −C/−C +A/+T eettcc
1-4 +A/+A −C/−C +A/+A eettcc
T1 #3 +T/+T +T/+G +G/+T eettcc
T2 3-1 +T/+T +G/+G +G/+T eettcc
3-2 +T/+T +G/+G +T/+T eettcc
3-3 +T/+T +G/+G +G/+T eettcc
3-4 +T/+T +G/+G +G/+T eettcc
T1 #C1 +C/+A +T (×13)/−G (×11) +G/+G eettcc
T2 C1-17 +A/+A +T/+T +G/+G eettcc
All mutations but TRY from #C1 in this experiment were single-base insertions
or deletions by direct sequencing of PCR products and the inserted (+) or
deleted (−) nucleotide is denoted. TRY mutations in #C1 were detected by
sequencing of cloned PCR products, and the number of the same type of
mutation is indicated in parentheses. Two types of mutations from direct
sequencing of PCR products were obtained based on double-peaks on
chromatograph. Two alleles are separated by ‘/’. eettcc corresponds to etc2 try
cpc triple mutant. C1-17 is a nontransgenic T2 line derived from #C1
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or Surveyor assay (Additional file 3: Figure S5). After these
primary screens, users will be able to quickly obtain a few
candidate lines for sequence analysis (including direct se-
quencing of PCR fragments, sequencing individual clones
of PCR fragments, and deep sequencing of PCR fragments)
(Additional file 3: Figure S5).
To confirm that the T1 mutations are germline trans-
missible, we sowed 20 T2 seeds per T1 line derived from
the two T1 triple mutant lines (#1 and #3) on MS plates.
We observed no phenotypic segregation of these T2
plants (Table 2). Moreover, sequencing analysis of four
T2 plants per T1 line showed no novel mutation typesTable 2 Phenotypic segregation analysis of T2 transgenic lines
T1 LTMs/Total-T2 T1 LTMs/Total-T2 T1 LTMs/Total-T2
1 20/20 (100 %) 9 0/83 (0) 17 11/34 (32.4 %)
2 0/162 (0) 10 33/156 (21.2 %) 18 0/42 (0)
3 20/20 (100 %) 11 27/49 (55.1 %) 19 0/53 (0)
4 42/98 (42.9 %) 12 0/78 (0) 20 0/36 (0)
5 15/47 (31.9 %) 13 0/52 (0) 21 18/45 (40.0 %)
6 25/77 (32.5 %) 14 0/202 (0) 22 n.a.
7 13/64 (20.3 %) 15 0/57 (0) 23 57/94 (60.6 %)
8 0/56 (0) 16 0/38 (0) 24 53/90 (58.9 %)
LTMs, likely triple mutants, that is, T2 plants with phenotypes similar to those
of try cpc etc2 triple mutants; Total-T2, total number of T2 plants examined;
n.a., not available. The average segregation ratio of the LTMs to total T2 plants
examined was 24.8 % ((100 % + 100 % + 42.9 % +… + 58.9 %)/24). The T2
seeds from #1 and #3 were sown on MS medium whereas those from the
other T1 lines were sown on hygromycin (25 mg/L) medium(Table 1). These results strongly suggested that germline
transmission of T1 mutations occurred. To further con-
firm the germline transmission of the T1 mutations, we
screened for non-transgenic T2 lines and analyzed their
mutations. Since we harvested <30 T2 seeds per T1 line
from the two triple mutant T1 lines (#1 and #3) due to
their poor growth, no additional T2 seeds were available
for screening of non-transgenic lines. We then turned to
screening for non-transgenic T2 plants derived from the
T1 triple mutant (#C1) produced in the third transform-
ation (Additional file 1: Figure S2). We sowed 36 T2
seeds on MS plates, and transplanted the seedlings to
soil. All 36 T2 plants were phenotypically triple mutants.
We screened all 36 T2 plants for non-transgenic plants
and obtained only one such plant, much fewer than the
nine or so plants we expected, which may reflect inser-
tions of two or more copies of T-DNAs into the genome
of the T1 plant. We analyzed the mutations of the T1
mutant (#C1) and the non-transgenic T2 mutant (#C1-
17) by sequencing (Table 1), which demonstrated that
the T2 mutations are derived from the originally con-
firmed, rather than newly produced, T1 mutations
through germline transmission (Table 1).
Analysis of mutations in the phenotypically wild-type T1
plants and their T2 progeny
Since CRISPR/Cas9 should continue to function in T1
egg cells, T2 one-cell stage embryos, and T2 early em-
bryos, and since T1 plants with normal phenotypes
might be heterozygotes or mosaics rather than wild type,
T1 plants with no clear phenotypes should be able to
give rise to homozygous or bi-allelic triple mutant T2
plants. To ensure that triple mutants could be differenti-
ated from double mutants, we re-examined the pheno-
types of the triple/double mutants, finding no
differences from our previous observations (Additional
file 3: Figure S6). Then, we examined T2 plants derived
from the 24 T1 EC1.2p:zCas9-rbcS_E9t lines, revealing
that approximately 50 % (12/24) produced likely triple
mutant T2 progeny (Fig. 2 and Table 2). The segregation
ratio of the likely triple mutants to total T2 plants exam-
ined was higher than 20 % for each of the 12 T1 lines
and averaged 24.8 % for all 24 T1 lines (Table 2). Of the
54 T1 EC1.2p:zCas9-Nost lines (>100 T2 plants per line
examined), only two lines, equivalent to 3.7 % (2/54),
produced likely triple mutants in their T2 progeny.
These results further demonstrate that the combination
of EC1.2 promoter and rbcS E9 terminator performed
much better than the EC1.2 promoter and nos termin-
ator combination, suggesting that in egg cells, the ter-
minator is a key factor in stabilizing the Cas9 mRNA
and thus enhancing its translation.
We sequenced the three target genes of two represen-
tative T1 lines (#4 T1 and #6 T1), which had normal
Fig. 2 Phenotypic segregation of T2 transgenic lines. Phenotypic segregation of T2 transgenic lines derived from two representative T1 lines with
normal phenotypes. Seeds from T0 plants were sown on MS medium containing 25 mg/L hygromycin, vernalized at 4 °C for 3 days, and grown
under long-day conditions (16 h light/8 h dark) at 22 °C for 7 days. Hygromycin-resistant seedlings (T1) were transplanted to soil and allowed to
grow for 20 days before photographing
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triple mutant T2 progeny (10 T2 plants per line; Table 3).
The sequencing results revealed that the two T1 lines
were mosaic with different degrees of mutation in the
three target genes, demonstrating that the mutation fre-
quency of a single gene in the T1 population was much
higher than the frequency of simultaneous mutations of
all three target genes. The formation of mosaic plants
could be attributed to Cas9 mRNA and protein stability
(Additional file 2: Table S2). For example, for a two- or
four-celled embryo derived from a zygote that had
undergone two or three rounds of mitosis, each of the
two or four cells would contain three-quarters or half
the amount of Cas9 protein of that in the egg cell (if
Cas9 mRNA and protein were sufficiently stable;
Additional file 2: Table S2). Two types of mosaic plants
resulted from EC1.2p:Cas9 transformation: mosaics with
a wild-type allele of a target gene and mosaics without
wild-type alleles, which could be regarded as homozy-
gous mutants. Analysis of the mutations present in the
T2 progeny of the T1 mosaic plants demonstrated that
most of the triple-mutant-like T2 plants were homozy-
gous or biallelic triple mutants (Table 3).
Functional comparisons of 12 combinations of eight
promoters and two terminators
In an attempt to improve the efficiency of generating T1
homozygous mutants, we first tested another egg-cell spe-
cific promoter, using the promoter from EC1.1, and then
we tested EC1.2 or EC1.1 promoters fused with enhancers
(Fig. 3). Similar to our tests of the EC1.2 promoter, we also
tested two combinations of the EC1.1 promoter with the
rbcS E9 terminator (pHEE2B-TRI) or nos terminator
(pHEN2B-TRI) to further examine the effects of termina-
tors on mutation efficiencies (Fig. 3a). We obtained 32plants with observable mutations out of 224 T1 EC1.1p:z-
Cas9-rbcS_E9t transgenic lines (Additional file 4: Figure
S7). However, most plants with observable mutations
seemed to be likely double mutants or mosaics, and only
four plants seemed to be likely triple mutants (Additional
file 4: Figure S7), suggesting that the EC1.1 promoter is less
egg cell-specific than the EC1.2 promoter. The existence of
a high ratio of mosaics means that the likely triple mutants
(1.8 %) from EC1.1p:zCas9-rbcS_E9t transgenic lines are
more likely to be phenotypically severe mosaics. We ob-
tained only three mosaic plant out of 102 T1 EC1.1p:z-
Cas9-Nost transgenic plants (Fig. 3a), demonstrating for
the third time that the rbcS E9 terminator performed much
better than the nos terminator. To exclude the possibility
that the pGreen backbone of pHEN2A-TRI and pHEN2B-
TRI was the reason for the low mutation efficiencies, we
constructed pHEN2C-TRI by replacing the rbcS E9 termin-
ator of pCambia1300-derived pHEE2A-TRI with the nos
terminator (Fig. 3a). We obtained only four likely double
mutants out of 134 T1 EC1.2p:zCas9-Nost (pCambia) lines,
demonstrating for the fourth time that the rbcS E9 termin-
ator performed much better than the nos terminator, and
the effects of the terminators were independent of the back-
bones of the binary vectors.
In our previous work, we demonstrated that constitutive
overexpression of zCas9 driven by the double 35S promoter
in T1 2x35Sp:zCas9-Nost transgenic lines (using construct
p2gR-TRI-A, renamed pHSN2A-TRI in this paper) effi-
ciently produced mutations for TRY, CPC, and ETC2, but
all the mutants were mosaics [26]. Since EC1p/rbcS-E9t
combinations (pHEE2A-TRI and pHEE2B-TRI) performed
much better than EC1p/Nost combinations (pHEN2A-TRI,
pHEN2B-TRI, and pHEN2C-TRI), we reasoned that the
2x35Sp/rbcS-E9t combination (pHSE2A-TRI) would per-
form much better than the 2x35Sp/Nost combination
Table 3 Mutation analysis of likely triple mutants segregated from two representative T1 lines with normal phenotypes
Line ETC2 mutation TRY mutation CPC mutation Genotype
T1 #4 0/0 +G (×3)//+A (×9)//−G (×7)//+C (×2) 0/0 EEtxCC
T2
4-1 +C/+T −G/−G +A/+A eettcc
4-2 +A/+A −G/−G −8 (×8)/−G + T (×2) eettcc
4-3 +T (×9)/+5 (×11) +A (×7)/−5 (×3) +G (×4)/−14 + 4 (×6) eettcc
4-4 −41 (×9)/−24 (×11) −G/−G −G/−G eettcc
4-5 −14 + A (×13)/+A (×7) −G/−G −3/−3 eettcc
4-6 −5/−5 +G (×8)/−G (×2) +G/+A eettcc
4-7 +T/+A +C/+C +G/+T eettcc
4-8 +T/+T −G/−G +G/+A eettcc
4-9 +C/+T −G (×7)/−8 (×3) +G/+G eettcc
4-10 +G/+G +T (×3)/−G (×7) 0 (×13)//+G (×2)//+A (×1)//+T (×2) eettcx
T1 #6 +A (×2)//−5 (×1)//−41
(×2)//−52 + 9 (×3)//−24 (×2)
0 (×4)//+G (×5)//−G (×8)//−22 + 16 (×5) 0/0 extxCC
T2
6-1 −52 + 9/−52 + 9 −22 + 16(×6)/−3(×5) 0 (×7)//+T (×1)//+A (×1) eettcx
6-2 +T/+T −G (×10)//+G (×5)//−26 (×4) 0 (×15)//+A (×2)//+T (×1)//−14 + 4
(×1)//−11 (×2)
eetxcx or eettcx
6-3 −52 + 9/−52 + 9 +T (×5)//+G (×3)//−G (×2)//−22 + 16 (×3) +A (×5)/+A (×5) eetxcc or eettcc
6-4 −52 + 9/−52 + 9 −22 + 16/−22 + 16 +G/+A eettcc
6-5 −52 + 9/−52 + 9 −22 + 16 (×5)/+G (×3) +A/+T eettcc
6-6 −41 (×5)//−24 (×3)//−30 + 17
(×2)//+A (×2)
−G (×8)//+G (×2)//−22 + 16 (×1) +A (×1)/+T (×8) extxcc or eettcc
6-7 −4 (×16)/+G (×4) −G/−G −G (×9)/+C (×2) eettcc
6-8 +C (×10)/−49 (×10) −G/−G +T/+T eettcc
6-9 −52 + 9/−52 + 9 +A (×5)//−G (×2)//−22 + 16 (×1) +A/+T eetxcc or eettcc
6-10 +A/+T −G/−G +T/+T eettcc
‘+’ indicates insertion, ‘–’ indicates deletion, ‘0’ indicates no mutation (wild-type allele). The number following ‘+’ or ‘–’ indicates the number of bases inserted or
deleted; if the number is 1, it is replaced with a specific base. Mutations were detected by direct sequencing of PCR products or sequencing of cloned PCR
products. Two types of mutations from direct sequencing of PCR products were obtained based on double-peaks on a chromatograph. When mutations were
detected by sequencing of cloned PCR products, the number of the same type of mutation is indicated in parentheses. Two alleles (in WT, homozygous or biallelic
mutants, or heterozygous mutants) are separated by ‘/’, whereas more than two alleles (in mosaic plants, underlined) are separated by ‘//’ between two alleles. For
genotypes, E/T/C corresponds to the wild-type ETC2/TRY/CPC gene, e/t/c corresponds to etc2/try/cpc mutant gene, x corresponds to multiple alleles, resulting in
mosaic plants
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and obtained 109 T1 2x35Sp:zCas9-rbcS_E9t transgenic
lines. None of the T1 lines are likely triple mutants (Fig. 3a),
demonstrating again that almost all mutants produced from
the T1 2x35S:Cas9 transgenic lines are mosaics. The ratios
of mutants from T1 2x35Sp:zCas9-rbcS_E9t lines with
strong (30.3 %) or observable (68.8 %) phenotypes to total
number of T1 lines are much lower than those from T1
2x35Sp:zCas9-Nost lines (78.8 % and 97.0 %, respectively).
These results demonstrated that 2x35Sp/rbcS-E9t combin-
ation did not perform much better than 2x35Sp/Nost
combination, suggesting that in vegetative cells, the nos ter-
minator seemed to work better than the rbcS-E9 termin-
ator. Considering statistical errors (for example, due to
insufficient sample population for 2x35Sp:zCas9-Nost
transgenic lines), another possibility is that zCas9 mRNA
stability is not as important for strong constitutive pro-
moters as it is for egg cell-specific promoters.To determine whether the 35S enhancer could increase
the expression driven by the egg cell-specific promoters,
we constructed three fusion promoters by fusing the 35S
enhancer with the egg cell-specific promoters and then
generated transgenic lines for the analysis of these fusion
promoters’ activities (Fig. 3b). The ratio (26/67, 38.8 %) of
35Sen-EC1.1p:zCas9 plants with observable mutations to
the total number of T1 transgenic lines was much higher
than that (32/224, 14.3 %) of EC1.1p:zCas9-rbcS_E9t
plants with observable mutations (Fig. 3b). In comparison
with the ratio for T1 EC1.2p:zCas9-rbcS_E9t transgenic
lines, the ratios of plants with observable mutations to
total numbers of T1 35Sen-EC1.2p(900-bp):zCas9 or
35Sen-EC1.2p(565-bp):zCas9 transgenic lines greatly in-
creased – 11.1 % (12/108), 25.2 % (29/115), and 29.0 %
(20/69) for the three transgenic lines, respectively –
whereas the ratios of likely triple mutants decreased
(8.3 %, 3.5 %, and 1.4 % for the three transgenic lines,
Fig. 3 Structural and functional comparisons of twelve combinations of eight promoters and two terminators. a Seven combinations of EC1.1,
EC1.2, or 2x35S promoters and rbcS E9 terminator (rbcS-E9t) or nos terminator (Nost). The pHEN2A-TRI and pHEN2C-TRI constructs have the same
combination but different vector backbones: pGreen for the former and pCambia for the latter. The data for pHSN2A-TRI come from the publica-
tion and p2gR-TRI-A is renamed pHSN2A-TRI in this paper [26]. b Five combinations of five fusion promoters and the rbcS E9 terminator. Physical
maps of the T-DNAs of seven (a) or five (b) CRISPR/Cas9 binary vectors are indicated. For each binary vector, the vector name, the promoter, the
terminator, and the mutation frequencies of T1 transgenic plants are indicated at the same row under the maps. See Fig. 1 for RB/LB, zCas9, 2-
sgRs, and Hyg. EC1p, EC1.1p or EC1.2p; 35Sen, CaMV 35S enhancer; EC1.2en, enhancer from EC1.2 promoter; LTM, likely triple mutant; Total, total
number of T1 plants; Mosaics-I, type I mosaic plants with strong phenotypes indistinguishable from the double mutants; Mosaics-II, type II mosaic
plants with the phenotypes appearing only in some parts of the whole plants. The ratios of T1 plants with the mutations (LTMs, Mosaics-I, or
Mosaics-II) to total number of T1 plants are indicated
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CaMV 35S enhancer increased the expression of EC1.1 or
EC1.2 promoters but not in an egg cell-specific way. Thus,
the CaMV 35S enhancer is not suitable for improving the
EPC CRISPR/Cas9 system, which is consistent with our
notion that the CaMV 35S promoter has weak activity in
egg cells and one-cell stage embryos.
To determine whether the enhancer from the EC1.2
promoter or EASE [53] could improve the performance of
the EPC CRISPR/Cas9 system, we constructed another
two fusion promoters by fusing the enhancer from the
EC1.2 promoter (EC1.2en), or EC1.2en plus double EASE
enhancers (EC1.2en-2xEASE), with the EC1.1 promoter
(Fig. 3b). The ratio (17.0 %) of EC1.2en-EC1.1p:zCas9-
rbcS_E9t plant-derived likely triple mutants to total
number of T1 transgenic lines greatly increased (Fig. 3b,
Additional file 4: Figure S8) in comparison with those for
the EC1.2p/EC1.1p:zCas9-rbcS_E9t plant-derived mutants
(8.3 % and 1.8 %, respectively, Fig. 3a). The ratio (28.3 %)
of EC1.2en-EC1.1p:zCas9-rbcS_E9t plants with observable
mutations to total number of T1 transgenic lines also
greatly increased (Fig. 3b, Additional file 4: Figure S8) in
comparison with those for the EC1.2p/EC1.1p:zCas9-
rbcS_E9t plants with observable mutations (11.1 % and
14.3 %, respectively, Fig. 3a). These results demonstratedthat the EC1.2en-EC1.1p fusion promoter performed
much better than the single EC1.2 or EC1.1 promoters,
and the enhancer from the EC1.2 promoter significantly
improved egg cell-specificity and expression strength of
EC1.1 promoter. Unexpectedly, when we added double
EASE enhancers into the EC1.2en-EC1.1p fusion pro-
moter, the resultant fusion promoter caused lower muta-
tion efficiency: only 8.3 % (10/120) EC1.2en-2xEASE-
EC1.1p:zCas9-rbcS_E9t plants harbor the observable mu-
tations (Fig. 3b, Additional file 4: Figure S9). These results
suggested that EC1 and EASE have different mechanisms
for egg cell-specific expression, and the two mechanisms
seem to be antagonistic.
Discussion
For most plants, including crops, genetic transformation
is usually performed with embryogenic callus cells in-
duced during tissue culture. Recent studies have demon-
strated that embryogenic cell-derived transgenic lines
expressing the CRISPR/Cas9 system could be homozygous
mutant for edited target genes in the first generation
[26–28, 33]. For Arabidopsis, the only plant species cur-
rently compatible with efficient, in planta transformation,
most modifications detected in first-generation CRISPR/
Cas9 transgenic lines were only somatic mutations [20, 25,
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ing of heritable mutations should be performed in the T2
or subsequent generations [35]. However, we reasoned
that the excess of mosaic plants and lack of homozygous
mutants was probably due to the low expression level of
Cas9 driven by constitutive promoters (usually the 35S
promoter) in egg cells and one-cell stage embryos. Due to
the stability of Cas9 mRNA and Cas9 protein, CRISPR/
Cas9 specifically expressed in egg cells should function in
one-cell embryos, allowing the creation of homozygous or
bi-allelic T1 mutants. Consistent with this notion, in the
current study, we used an egg cell-specific promoter to ex-
press Cas9 and succeeded in creating T1 homozygous (or
bi-allelic) mutants harboring two or three target genes
that were modified simultaneously. More importantly,
since approximately 8.3 % and 13.1 % of T1 plants are
non-mosaic triple and double mutants for the representa-
tive three and two target genes, respectively, we demon-
strated that mutation efficiencies of the system would be
sufficient for producing customized Arabidopsis mutants.
Although some mosaics still formed in T1 and T2 plants
due to Cas9 mRNA and/or protein stability (Table 3, Add-
itional file 2: Tables S1 and S2), these mosaics were de-
rived from early embryos (probably two- or four-celled
embryos) and were thus stable in terms of the types and
patterns of mutations (Additional file 2: Table S2). There-
fore, some mosaic plants harboring more than two mutant
alleles but lacking wild-type alleles are equivalent to
homozygous (or bi-allelic) mutants in phenotypes or
gene-specific traits. By contrast, the mutation types and
patterns of the mosaic plants resulting from 35Sp:Cas9
transformation were usually unstable and variable
throughout development and in different tissues or or-
gans. So, even if some mosaics would be unavoidable to
be produced from EC1.2p:Cas9, these mosaics could pro-
duce much higher ratios of homozygous (or bi-allelic) mu-
tant progeny harboring much more highly predictable
mutation types than mosaics from 35S:Cas9 could do.
Therefore, the mosaics, if unavoidable, from EC1.2p:Cas9
or EC1.2en-EC1.1p:Cas9 are more useful for screening for
homozygous mutant progeny, especially non-transgenic
homozygous mutants in T2 generation, than those from
35S:Cas9 are (Additional file 3: Figure S4).
Ma et al. [54] recently reported that using 2x35Sp:Cas9p
they obtained about 8.5 % non-mosaic T1 mutations (10
out of 118 sequenced target sites). Since these sequenced
target sites involved six target sites in four genes (three tar-
gets in the same gene and three targets in three other
genes) of about 100 T1 lines, this means that they obtained
approximately 9.0 % (9/100) non-mosaic T1 mutants. They
obtained one T1 mutant, out of 14 T1 lines, with non-
mosaic, simultaneous mutations of two target sites of the
same gene. However, they failed to obtain the mutants (0/
14) with simultaneous mutations of three target sites. Theseresults suggest that 2x35Sp:Cas9 transgenic lines have
much lower mutation efficiencies for the generation of T1
homozygous or biallelic mutants for multiple target genes
than EC1.2p:Cas9 transgenic lines, which is consistent with
our results.
In this study, to evaluate mutation efficiencies and de-
termine the size of the T1 population needed for screen-
ing for homozygous mutants, we used screenable
phenotypes for the identification of the triple or double
mutants. In practical applications, the genes-of-interest
might have no convenient, visible phenotype. One po-
tential, low-cost strategy for identifying mutants is to se-
lect, as far as possible, targets with cleavage sites located
within restriction enzyme sites. In this case, users can
conduct primary screening by restriction enzyme diges-
tion analysis (Additional file 3: Figure S5), as the occur-
rence of a mutation should disrupt the restriction
enzyme site [26]. Alternatively, users could conduct pri-
mary screening by T7E1 or Surveyor assay [8, 22]. Then,
users can perform sequencing analysis, based on three
strategies, of primarily screened lines that likely are bi-
allelic mutants (Additional file 3: Figure S5). One strat-
egy is direct sequencing purified PCR fragments span-
ning target sites using primers within PCR fragments.
For homozygous (or bi-allelic) mutations with a one base
pair insertion or deletion, this strategy would work well.
Sequencing of individual clones of PCR fragments and
deep sequencing of PCR fragments can also be used to
identify non-mosaic, mutant plants. However, the high
frequencies of mutations induced by this method will
also allow users to identify non-mosaic mutants by using
the simplest and most effective (but also expensive)
method, deep sequencing of PCR fragments spanning
target sites from 25–50 T1 transgenic lines.
Some targets may have much lower mutation efficien-
cies than others, so we suggest selecting three sets of
targets, with two sets as backups to avoid being delayed
by possibly recalcitrant targets (Additional file 3: Figure
S5). Construction of a binary vector harboring two
sgRNAs is very simple and only a single additional PCR
fragment is required for the cloning system [26]. There-
fore, even for targeted mutation of a single gene, we sug-
gest always constructing a binary vector that harbors
two sgRNAs targeting two sites in the same gene. Thus,
with two backup vectors, this method provides sextuple
assurance of getting targeted mutations of a single gene.
A critical finding in this study is that one of the key
factors determining our success with the EPC CRISPR/
Cas9 system was the presence of a suitable terminator.
T1 and T2 plants with observable mutations (including
likely triple/double mutants and mosaics) were infre-
quent when these plants were derived from EC1.2p:z-
Cas9-Nost transgenic lines, which used the nos
terminator. By contrast, an average of 24.8 % T2 plants
Wang et al. Genome Biology  (2015) 16:144 Page 9 of 12derived from EC1.2p:zCas9-rbcS_E9t, which used the
rbcS-E9 terminator, were likely triple mutants (Table 2).
Indeed, while the use of the same promoter with differ-
ent terminators has been shown to sometimes result in
significantly different levels of protein accumulation
[51], the large difference in mutation efficiencies ob-
served between the two terminators in the current study
was unexpected. Comparison of mutation frequencies of
additional constructs (pHEE2B-TRI and pHEN2B-TRI,
or pHEE2A-TRI and pHEN2C-TRI) provided additional
proof that the rbcS E9 terminator performed much bet-
ter than the nos terminator (Fig. 3). These results sug-
gest that the presence of the proper terminator is a key
factor in stabilizing Cas9 mRNA in egg cells, and differ-
ent terminators have significantly different effects on
Cas9 mRNA stability.
CRISPR/Cas9-based multiplex genome editing requires
multiple sgRNAs and maintaining appropriate concentra-
tions of each variant of sgRNA-Cas9 complex in a cell for
target search according to the target recognition mechan-
ism [55]. Since methods have been developed to assemble
multiple sgRNAs [26, 37, 54, 56, 57], highly efficient ex-
pression of multiple sgRNAs in a cell has not been a prob-
lem. However, co-existence of multiple sgRNAs in a cell
would dilute the concentration of each variant of the
sgRNA-Cas9 complex harboring a specific target se-
quence. Thus, although the total concentration of all
sgRNA-Cas9 complexes may remain stable, the functional
concentration of each variant of the sgRNA-Cas9 complex
would decrease in inverse proportion to the numbers of
sgRNA variants or target sites. Thus, it is important to ex-
press Cas9 more efficiently to increase the concentration
of each variant of the sgRNA-Cas9 complex and thus en-
hance the efficiency of multiplex genome editing. Consist-
ent with this notion, our results demonstrated that
mutation efficiencies for multiple targets could be greatly
increased by using not only appropriate promoters to
drive the expression of Cas9 but also appropriate termina-
tors to stabilize Cas9 mRNA. These observations should
facilitate development or improvement of genome editing
methods for the generation of non-mosaic mutants for
multiple target genes in other organisms, especially
through specific expression of CRISPR/Cas9 in germline
cells, gametes, or one-cell stage embryos [58]. Although
currently Arabidopsis is the only species amenable to in
planta transformation method with high efficiency, along
with the development of in planta transformation for
other plants, it is possible that the egg cell-specific
promoter-controlled CRISPR/Cas9 system or similar strat-
egies will be very useful for more plant species.
Localized egg-cell expression of a ZFN was previously
employed for targeted editing of the Arabidopsis genome
[59]. In this case, the EASE:QQR-ZFN expression cas-
sette was used; EASE is an enhancer sequence thatspecifically regulates gene expression in the egg appar-
atus of Arabidopsis, and QQR-ZFN is a well-
characterized ZFN that functions in planta [53, 59].
However, the reported mutation frequencies were not
high enough for practical application. No mutations
were detected in T1 EASE:QQR-ZFN plants, and the
mutation frequency of T2 plants was only 0.078 % (7/
9000) in a GUS staining assay and only 0.27 % (1/366) in
a PCR-based assay. Even if the actual mutation rate were
underestimated, the mutation frequency of T2 plants
was not much higher than 0.5 % for the single target
gene. By contrast, in our EC1.2p:Cas9-based system, ap-
proximately 8.3 % of the T1 plants and an average of
24.8 % of the T2 plants were likely triple mutants
(Table 3). These results might reflect the differences be-
tween CRISPR/Cas9 and ZFN, between EC1.2p and
EASE, and/or between the terminators used in the two
cassettes.
Although the mutation efficiencies that can be obtained
using the EC1.2 promoter-controlled CRISPR/Cas9 system
are high enough to allow researchers to customize their
own Arabidopsis mutants, higher target gene editing effi-
ciencies can be anticipated. As an example, the fusion pro-
moter from two egg cell-specific genes EC1.2 and EC1.1
resulted in much higher efficiency of mutation compared
with the single promoters. By fusing more enhancers from
the EC1 genes (including EC1.1–EC1.5) to the EC1.1 or
EC1.2 promoter [50], stronger and more specific expression
of Cas9 in egg cells and one-cell stage embryos could be
anticipated. In addition, by using more effective terminators
than rbcS E9 terminator, the EPC CRISPR/Cas9 system
could be further improved. The optimized combinations of
fusion promoters and terminators will greatly enhance the
mutation efficiencies. It has been shown that, after transfec-
tion by Agrobacterium, the ratio (7 %) of ovules demon-
strating transient expression to total number of ovules
examined was much higher than ratio (0.44 %) of ovules
developing into stable transgenic seeds to total number of
ovules/seeds examined [59]. Thus, this enhanced system
would allow us to create non-transgenic, gain-of-function
T1 mutants via homologous recombination mediated by
the EPC CRISPR/Cas9 system, which is currently a formid-
able challenge [35]. Finally, with the development of high-
throughput sequencing, deep sequencing of large batches
of PCR products will become affordable and the time re-
quired to identify targeted gene modifications will be fur-
ther shortened.
Conclusions
Probing gene function and examining gene interactions
requires the generation of single, double, and multiple
mutants in different combinations. However, in plants,
generation of these mutants requires screening of banks
of existing mutants, followed by laborious and time-
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New genome-editing methods, such as the CRISPR/Cas9
system, can be used to generate targeted gene modifica-
tions in Arabidopsis; however, almost all first-generation
CRISPR/Cas9 transgenic Arabidopsis plants have been
mosaic for the targeted genes. This study demonstrates
that specifically expressing Cas9 in egg cells and one-
cell stage embryos enables the creation of homozygous
or biallelic T1 mutants for multiple target genes with
high efficiency: 2 of 24 (8.3 %) of the T1 plants were
homozygous or biallelic cpc try etc2 triple mutants.
Moreover, 12 of the 24 T1 plants gave rise to homozy-
gous triple mutants in the T2 generation. The segrega-
tion ratio of likely triple mutants to total T2 plants was
over 20 % for all 12 T1 lines and averaged 24.8 % for all
24 T1 lines. We also generated chli1 chli2 homozygous
or biallelic double mutants with a ratio of 13.1 % (13/99)
in T1 generation. Comparisons of 12 combinations of
eight promoters and two terminators found that the effi-
ciency of the egg cell-specific promoter-controlled (EPC)
CRISPR/Cas9 system depended on the presence of a
suitable terminator, and the fusion promoter from two
egg cell-specific genes EC1.2 and EC1.1 resulted in much
higher efficiency of mutation in the T1 generation com-
pared with the single promoters. This system provides a
rapid, cost-effective way to create new mutant populations
and multi-gene mutants in Arabidopsis. This study also pre-
sented a route to optimize the EPC CRISPR/Cas9 system.
Methods
Vector construction
Detailed descriptions of the vector construction are pro-
vided in Additional file 5: Methods S1. All primers used
in this study are listed in Additional file 2: Table S3. The
vector sequences are provided in Additional file 6.
Generation of transgenic Arabidopsis plants and analysis
of mutations
We transformed the pHEE2A/B/D1/D2/D3/E/F-TRI,
pHEN2C-TRI, pHSE2A-TRI, and pHEE2A-CHLI con-
structs into Agrobacterium strain GV3101, and trans-
formed pHEN2A/B-TRI into GV3101/pSoup [26]. We
transformed Arabidopsis Col-0 wild-type plants via the
floral dip method [45]. We screened the collected seeds
from the T0 plants on MS plates containing 25 mg/L
hygromycin, and transplanted the resistant seedlings
(T1) to soil. We extracted genomic DNA from T1 trans-
genic plants grown in soil. To analyze mutations of TRY,
CPC, and ETC2, we amplified fragments surrounding
the target sites of TRY, CPC, or ETC2 by PCR using
gene-specific primers TRY-IDF0/R0, CPC-IDF0/R0, or
ETC2-IDF0/R0, respectively [26]. We submitted purified
PCR products for direct sequencing with primers TRY/
CPC/ETC2-seqF [26] located within the PCR fragments.To analyze possible mutations of potential off-target
sites of TRY, CPC, and AT5G50230 of the sgRNA target-
ing ETC2, we amplified fragments surrounding the off-
target sites by PCR using gene-specific primers TRY-off-
IDF/R, CPC-off-IDF2/R, or 5G50230-off-IDF/R, respect-
ively. We submitted purified PCR products for direct se-
quencing (as opposed to sequencing of individual clones
of PCR products) with primers TRY/CPC/5G50230-off-
seqF located within the PCR fragments. To analyze mu-
tations of CHLI1 and CHLI2, we amplified fragments
surrounding the target sites of CHLI1 or CHLI2 by PCR
using gene-specific primers CHLI1-IDF/R or CHLI2-
IDF/R, respectively. We submitted purified PCR prod-
ucts for direct sequencing with primers CHLI1/2-seqF
located within the PCR fragments. We then cloned
poorly sequenced PCR products, and submitted individ-
ual positive clones for sequencing using the T7 primer.
To screen the segregated non-transgenic T2 plants, we
first screened nine primer combinations, with three for-
ward primers including zCas9-IDF3-2/-IDF5/-IDF6 (lo-
cated at zCas9) and three reverse primers including
rbcS_E9t-IDR/-IDR2 (located at rbcS-E9 terminator) and
lacp-IDF (located at the lac promoter of the vector back-
bone), for more specific primers (Additional file 2: Table
S3). We obtained three more specific primer pairs, in-
cluding zCas9-IDF3-2/rbcS_E9t-IDR2, zCas9-IDF5/lacp-
IDF, and zCas9-IDF6/lacp-IDF, with wild-type genomic
DNA serving as a negative control and genomic DNA
from T1 transgenic plants serving as a positive control
(Additional file 2: Table S3). We then performed coun-
terselection PCR with the three primer pairs for screen-
ing of non-transgenic T2 plants.
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obtained from the second round of transformation. Figure S2.
Arabidopsis T1 likely triple mutants obtained from the third round of
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Additional file 2: Table S1. Mutation analysis of T1 albino mutants.
Table S2. Supposed Cas9 protein dynamics during early embryo
development. Table S3. Primers used in this study.
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T1 homozygous mutants via EPC CRISPR/Cas9. Figure S5. Strategy for
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